EFPIA - NEWSLETTER

EFPIA Newsletter 04 July 2024

News

04 July 2024 Joint Statement for an Ambitious FP10

Investing in Europe’s Future Competitiveness through Collaborative Research, Development, and Innovation

28 June 2024 Strategic Agenda 2024-2029: an opportunity to close the gap with other regions of the world...

As we begin a new EU mandate, the focus on competitiveness of the Strategic Agenda gives us an opportunity to restore...

Blogs

04 July 2024 Cardiovascular health: urgent action needed on EU’s #1 killer

Innovation and competitiveness must be at the heart of Council Conclusions on cardiovascular health

Watch Nathalie Moll's speech at the Congress on Priorities and Challenges in Polish and European Drug Policy

On 5 June, Nathalie Moll participated in a panel of experts discussing the European pharmaceutical package and drug safety.

Watch the recordings below:

- European Pharmaceutical Package – a real game changer in health policy?

- Drug safety – European perspective on drug availability and development of local production

Recently published

New data demonstrates the value of regulatory data protection (RDP), and its impact on European competitiveness and patient access to medicines

New data from Copenhagen Economics shows that out of 53 countries – with and without RDP –patients in countries with RDP have three times higher availability of innovative medicines than those without, and significantly almost half of the difference in availability can be attributed to RDP.

Read more here.

What we are reading

The call for an EU Action Plan for rare diseases 04 July 2024 (POLITICO)

Making cardiovascular health a European health priority will save millions of lives 03 July 2024 (Euractiv)

Niklas Blomberg, Executive Director, EU Innovative Health Initiative 03 July 2024 (Vital Health Podcast)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶